title: [Evaluation of metabolic control targets in patients with type 2 diabetes mellitus].
abstract: OBJECTIVE
  To evaluate the extent to which metabolic targets in type 2 diabetes (DM-2) are achieved in the Endocrinology and Clinical Nutrition Unit of the Hospital Puerta del Mar in Cadiz (Spain) from 2005 to 2008.
  
  
  METHODS
  The database included in the computer application HP-Doctor used for all patients attended in our unit (admissions, consultations and peripheral centers) was analyzed. All patients with a principal or secondary diagnosis of DM-2 were included. Clinical characteristics, chronic complications, drug treatment and the percentage of patients who achieved annual mean targets of glycosylated hemoglobin (HbA1c) and low-density lipoprotein cholesterol (LDLc) were analyzed.
  
  
  RESULTS
  From 2005 to 2008, the number of DM-2 patients with computerized records increased by 108.7%. In 2008, 1,177 patients were evaluated. A total of 10.8% were active smokers, 53% had hypertension, and 51.2% and 12.6% presented with retinopathy and cardiovascular disease, respectively. During the study period, the percentage of patients with a mean HbA1c <7% was similar (2005: 31.7% 2008: 30.4%), those with LDLc <100 mg/dl increased from 19.2% to 25.6% and only 9.2% of patients achieved both targets, HbA1c <7% and LDLc <100 mg/dl.
  
  
  CONCLUSIONS
  In 2008, only 30% of DM-2 patients achieved a mean HbA1c < 7% and only 25% had LDLc < 100 mg/dl. Metabolic control in DM-2 patients should be improved.
authors.affiliation: Unidad de Gestión Clínica, Endocrinología y Nutrición, Hospital Universitario Virgen de la Victoria, Málaga, España. maroca80@hotmail.com
authors.forename: María del Mar
authors.initials: Mdel M
authors.lastname: Roca-Rodríguez
authors.forename: Florentino
authors.initials: F
authors.lastname: Carral-San Laureano
authors.forename: Gloria
authors.initials: G
authors.lastname: Baena-Nieto
authors.forename: Manuel
authors.initials: M
authors.lastname: Aguilar-Diosdado
mesh_terms: D003924:Diabetes Mellitus, Type 2 / Q000378:metabolism* / Q000628:therapy*; D006801:Humans; D008875:Middle Aged